Skip to main content
. 2021 Jul 24;35:94. doi: 10.47176/mjiri.35.94

Table 4. Multiple Linear Regression Analysis for Assessing Association Between the Study Variables and Duration of Hospitalization for COVID-19*.

Variables Univariable Beta (95% CI) p Age-adjusted Beta (95% CI) p Multivariable Beta** (95% CI) p
Age > 60 yrs 0.17 (0.87 – 2.45) < 0.001 - - 0.89 (-0.02-1.80) 0.345
Male Gender 0.01 (-0.79 – 0.81) 0.980 -0.57 (-0.85-0.73) 0.887 - -
Body Mass Index > 30 kg/m2 0.44 (-0.48 – 1.36) 0.344 0.64 (-0.73-1.55) 0.173 - -
Diabetes 0.13 (0.54 – 2.30) 0.002 1.05 (0.16-1.94) 0.021 0.69 (-0.28-1.66) 0.164
Hypertension 0.12 (0.43 – 2.09) 0.003 0.71 (-0.18-1.60) 0.116 0.06 (-1.297-1.42) 0.931
Chronic Obstructive Pulmonary Disease / Asthma -0.00 (-1.50 – 1.36) 0.921 -0.42 (-1.84-0.99) 0.556 - -
Organ Failure# 2.58 (1.63 – 3.53) < 0.001 2.21 (1.24-3.18) <0.001 1.90 (0.76-3.04) 0.001
Cardiovascular disease# 1.72 (0.75 – 2.68) 0.001 1.15 (0.14-2.16) 0.026 0.065 (-1.09-1.22) 0.911
The Cancerous State# 1.74 (-5.29 – 4.01) 0.133 1.46 (-0.78-3.71) 0.201 1.244 (-0.96-3.48) 0.276
The Disability State# 1.90 (0.32 – 3.49) 0.019 1.25 (-0.35-2.85) 0.126 1.110 (-0.56-2.78) 0.194
Immunosuppression 0.04 (-0.93 – 2.42) 0.384 0.97 (-0.69-2.63) 0.251 - -
Taking ACEI or ARB 1.46 (0.56 – 2.36) 0.001 0.88 (-0.08-1.84) 0.073 0.274 (-1.15-1.70) 0.706
Tobacco use -0.013 (-1.78 – 1.29) 0.753 0.02 (-1.51-1.54) 0.985 - -

* OR: Odds Ratio; CI: Confidence Interval; ACEI: Angiotensin Converting Enzyme Inhibitor; ARB: Angiotensin Receptor Blocker ** All variables with P-value < 0.2 entered the model #’Organ Failure’ was defined as the presence of renal, heart or liver failure; ‘Cardiovascular disease’ as the presence of either coronary artery disease or cerebrovascular accident; ‘The Cancerous State’ as either receiving chemotherapy in recent 6 months or having active cancer; and ‘The Disability State’ as the presence of any physical or mental disabilities.